News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Mohamed Kharfan-Dabaja: Happy to Share Our Clinical Practice Recommendations in CLL on behalf of ASTCT
Mohamed Kharfan-Dabaja/mayoclinic.org
Jun 19, 2025, 13:21

Mohamed Kharfan-Dabaja: Happy to Share Our Clinical Practice Recommendations in CLL on behalf of ASTCT

Mohamed Kharfan-Dabaja, Vice Chair of Hematology at Mayo Clinic Comprehensive Cancer Center, shared a post on X:

“We are happy to share our recently published clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and CAR T-cell therapy in chronic lymphocytic leukemia on behalf of ASTCT.”

Title: Clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy in patients with chronic lymphocytic leukemia on behalf of the American Society for Transplantation and Cellular Therapy

Authors: Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Javier Pinilla-Ibarz, Jennifer R. Brown, Mazyar Shadman, Farrukh T. Awan, Saad S. Kenderian, Tanya Siddiqi, Jeremy S. Abramson, Taha Al-Juhaishi, Danielle M. Brander, Catherine C. Coombs, Richard R. Furman, Nitin Jain, Nadia Khan, Nakhle S. Saba, Jennifer M. Collins, Amer Beitinjaneh, Deborah M. Stephens, Jennifer Woyach, Mehdi Hamadani

Read Full Article.

Clinical Practice Recommendations

 

More Posts featuring Mohamed Kharfan-Dabaja.

Allogeneic Hematopoietic Cell Transplantation Ambuj Kumar Amer Beitinjaneh cancer CAR T-cell therapy Catherine C. Coombs Danielle M. Brander Deborah M. Stephens Farrukh T. Awan Javier Pinilla-Ibarz Jennifer M. Collins Jennifer R. Brown Jennifer Woyach Jeremy S. Abramson Mazyar Shadman Mehdi Hamadani Mohamed A. Kharfan-Dabaja Nadia Khan Nakhle S. Saba Nitin Jain OncoDaily Oncology Richard R. Furman Saad S. Kenderian Taha Al-Juhaishi Tanya Siddiqi
Special Coverage
Blog
Jun 19, 2025, 13:21
Mohamed Kharfan-Dabaja: Happy to Share Our Clinical Practice Recommendations in CLL on behalf of ASTCT
Oncolibrary
Jun 19, 2025, 13:13
New Paper Alert: KEYNOTE-689. Neoadjuvant and Adjuvant Pembrolizumab Improves Survival in Locally Advanced HNC
Blog
Jun 19, 2025, 13:04
Raul Cordoba Shared FOLL12 Trial on the Role of PET in Follicular Lymphoma
Oncolibrary
Jun 19, 2025, 13:01
Pancreatic Cancer Remission Rate: What Patients Should Know in 2025
Career
Jun 19, 2025, 12:40
Kristy Brown Received an $800,000 Grant Grom The V Foundation to Study How Obesity Impacts Cancer Research - KU Cancer Center
Science
Jun 19, 2025, 12:22
Justin Taylor: Happy to Share Our Latest Paper on XPO1 R749Q Mutations Online Ahead of Print in Cancer Research
Blog
Jun 19, 2025, 11:53
Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorites Drugs For Lung Cancer - Even Better Ones Are Yet to Come
Blog
Jun 19, 2025, 10:28
Enrique Soto Perez de Celis on the Global Mission of CU Cancer Center's International Fellowship Program
Insight
Jun 19, 2025, 09:48
Nicholas Hornstein: Watching the Center of Gravity in Oncology Drug Development Move
Blog
Jun 19, 2025, 09:37
Majority of Americans Oppose Cuts to Medical Research Funding - AACR
Positive
Jun 19, 2025, 09:29
Margaret Foti: Great to See Riccardo Dalla-Favera at ICML 2025
Insight
Jun 19, 2025, 09:24
Alberto Puccini and Massimo Di Maio Shared Report on Patient-Reported Outcomes in BMJ Oncology